ARX:ASX
Aroa Biosurgery Ltd
A$0.50
arrow_downward
-1.00%(-0.0050) 1D
Nov 16, 1:54:41 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.51
High
A$0.51
Low
A$0.50
Mkt. cap
171.22M
Avg. vol.
288.42K
Volume
54.60K
P/E ratio
47.23
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.51
High
A$0.51
Low
A$0.50
Mkt. cap
171.22M
Avg. vol.
288.42K
Volume
54.60K
P/E ratio
47.23
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
investingLive
·
1 hour ago
Morgan Stanley goes max overweight global stocks, sees 15% S&P 500 upside on AI capex
Yahoo Finance
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Edge Lower As Markets Brace For Nvidia Earnings, Anthropic IPO, Fed Minutes: SMMT, NBIS, HELP, MSTR In Focus
The Motley Fool
·
8 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
BigGo Finance
·
14 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd